BR100 Increased By (0.11%)
BR30 Decreased By (-0.1%)
KSE100 Increased By (0.17%)
KSE30 Increased By (0.15%)
AGHA 6.68 Increased By ▲ 0.07 (1.06%)
BECO 4.27 Increased By ▲ 0.03 (0.71%)
BML 60.36 Decreased By ▼ -1.09 (-1.77%)
BOP 28.83 Increased By ▲ 0.02 (0.07%)
CNERGY 12.88 Increased By ▲ 0.08 (0.63%)
CSIL 5.64 Increased By ▲ 0.08 (1.44%)
FCCL 51.85 Decreased By ▼ -0.14 (-0.27%)
FFL 14.08 Increased By ▲ 0.06 (0.43%)
FNEL 1.13 Increased By ▲ 0.01 (0.89%)
KEL 5.93 Increased By ▲ 0.02 (0.34%)
KOSM 5.40 Decreased By ▼ -0.04 (-0.74%)
LOTCHEM 25.63 Decreased By ▼ -0.19 (-0.74%)
MLCF 89.67 Decreased By ▼ -0.78 (-0.86%)
NBP 159.00 Decreased By ▼ -0.27 (-0.17%)
NCPL 48.90 Decreased By ▼ -0.18 (-0.37%)
NPL 52.56 Increased By ▲ 0.13 (0.25%)
OGDC 301.95 Decreased By ▼ -0.30 (-0.1%)
PACE 10.30 Increased By ▲ 0.44 (4.46%)
PAEL 33.72 Decreased By ▼ -0.01 (-0.03%)
PIBTL 13.70 Decreased By ▼ -0.01 (-0.07%)
PPL 219.36 Increased By ▲ 0.11 (0.05%)
PRL 105.40 Increased By ▲ 1.64 (1.58%)
PTC 53.70 Decreased By ▼ -1.36 (-2.47%)
SSGC 23.01 Decreased By ▼ -0.01 (-0.04%)
TBL 9.97 Increased By ▲ 0.20 (2.05%)
TELE 7.18 Decreased By ▼ -0.05 (-0.69%)
TPL 20.70 Increased By ▲ 0.03 (0.15%)
TPLP 11.89 Increased By ▲ 0.02 (0.17%)
TREET 23.80 Increased By ▲ 0.20 (0.85%)
TRG 56.50 Increased By ▲ 1.03 (1.86%)
By

WASHINGTON: US doctors announced Thursday they had successfully performed a double lung transplant on a patient with terminal lung cancer, giving new hope to others who also have advanced stages of the deadly disease.

Albert Khoury, a 54-year-old non-smoker, underwent a seven-hour surgery to receive his new lungs at Northwestern Medicine in Chicago on September 25, 2021.

Six months on, the lungs are working well and he has no signs of cancer in his body.

“Lung transplantation for lung cancer is extremely uncommon with few cases reported,” Ankit Bharat, chief of thoracic surgery at Northwestern Medicine, said in a statement.

“For patients with stage 4 cancer, lung transplantation is considered a complete ‘no-no,’ but because Albert’s cancer was confined only to his chest, we were confident we could clear all the cancer during surgery and save his life.” Surgeons are generally reluctant to proceed with such transplants because if there are even a few cancerous cells remaining, there is a strong chance they will regrow in a patient taking immune-suppressing medications to prevent organ rejection.

The few such procedures in the past have not been successful, but since then, advances have allowed doctors to better understand cancer’s spread.

Comments

Comments are closed for this article.